Uncategorized
Featured Stories
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
Six new studies from DaVita Clinical Research spotlight improved outcomes with GLP-1 use, advancements in treatments, transplant access and end-of-life care DENVER and HOUSTON, Nov. 4, 2025…
-
DaVita Inc. 3rd Quarter 2025 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2025. “Our third quarter performance was in line with our expectations and keeps us on track…
-
DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives
New U.S. data will offer first-of-its-kind evidence in patients with kidney failure DENVER, Oct. 20, 2025 /PRNewswire/ — DaVita today announced the launch of two groundbreaking initiatives aimed…
-
DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Wednesday, October 29, 2025, at 5:00 p.m. Eastern Time. The company…
-
DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care
As part of its 25th-anniversary celebration, DaVita, a leading provider of comprehensive kidney care, is proud to spotlight the groundbreaking work of its wholly owned research arm, DaVita…